Menova: Sacubitril Valsartan Sodium Tablets Obtained Drug Registration Certificate

On the evening of June 17, Menouhua announced that its wholly-owned subsidiary, Ningbo Menouhua Tiankang Pharmaceutical Co., Ltd., recently received the approval and issuance of the Drug Registration Certificate for Sacubitril/Valsartan tablets by the National Medical Products Administration. The indications for this drug are: used for the treatment of primary hypertension and chronic heart failure.